LV13127B - Pharmaceutical formulation consisting of a plant dry extract with a calcium coating - Google Patents

Pharmaceutical formulation consisting of a plant dry extract with a calcium coating Download PDF

Info

Publication number
LV13127B
LV13127B LVP-03-139A LV030139A LV13127B LV 13127 B LV13127 B LV 13127B LV 030139 A LV030139 A LV 030139A LV 13127 B LV13127 B LV 13127B
Authority
LV
Latvia
Prior art keywords
calcium
pharmaceutical preparation
preparation according
der
core
Prior art date
Application number
LVP-03-139A
Other languages
English (en)
Latvian (lv)
Inventor
Michael A Popp
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV13127(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of LV13127B publication Critical patent/LV13127B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-03-139A 2001-06-08 2003-12-03 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating LV13127B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10127897A DE10127897B4 (de) 2001-06-08 2001-06-08 Manteltablette mit Pflanzentrockenextrakten

Publications (1)

Publication Number Publication Date
LV13127B true LV13127B (en) 2004-05-20

Family

ID=7687662

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-03-139A LV13127B (en) 2001-06-08 2003-12-03 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

Country Status (28)

Country Link
US (2) US7629005B2 (hu)
EP (1) EP1392337B2 (hu)
JP (1) JP4945058B2 (hu)
KR (1) KR100894848B1 (hu)
CN (1) CN100376267C (hu)
AT (1) ATE311195T1 (hu)
AU (1) AU2002317720B2 (hu)
BG (1) BG66394B1 (hu)
BR (1) BR0210262A (hu)
CA (1) CA2449521C (hu)
CZ (1) CZ305121B6 (hu)
DE (2) DE10127897B4 (hu)
DK (1) DK1392337T4 (hu)
EA (1) EA006760B1 (hu)
EE (1) EE05360B1 (hu)
ES (1) ES2250674T5 (hu)
GE (1) GEP20053591B (hu)
HU (1) HUP0400125A3 (hu)
LT (1) LT5146B (hu)
LV (1) LV13127B (hu)
MX (1) MXPA03011102A (hu)
NO (1) NO20035274D0 (hu)
NZ (1) NZ529779A (hu)
PL (1) PL370446A1 (hu)
RO (1) RO122659B1 (hu)
SK (1) SK287722B6 (hu)
UA (1) UA76464C2 (hu)
WO (1) WO2002100422A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127897B4 (de) 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
US6767560B2 (en) * 2002-01-22 2004-07-27 Paul H Paek Fabrication method of oral care composition
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050238739A1 (en) * 2004-04-23 2005-10-27 Thomas Nisslein Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
EP1745796A1 (de) * 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
FR2893848B1 (fr) * 2005-11-28 2011-11-11 Physcience Composition phytohormonale et son utilisation comme substitut hormonal
AR059577A1 (es) * 2006-02-17 2008-04-16 Veritron Ltd Agente de aceleracion de absorcion del calcio
KR100758265B1 (ko) * 2006-04-07 2007-09-13 한국생명공학연구원 트리테르페노이드계 화합물을 유효성분으로 함유하는 심혈관계 질환의 예방 및 치료용 조성물
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
EP2545932A1 (de) 2011-07-12 2013-01-16 Bionorica Se Ausgewählte Cimicifuga-Fraktionen zur Behandlung von Osteoporose
WO2013007807A1 (de) 2011-07-12 2013-01-17 Bionorica Se Ausgewählte cimicifuga-fraktionen zur behandlung von osteoporose
WO2013074046A1 (en) 2011-08-08 2013-05-23 Mahmut Bilgic Pharmaceutical formulations comprising isoflavone
EP2946783A1 (de) 2011-08-19 2015-11-25 Bionorica Se Verfahren zur herstellung von trockenextrakten
EP2559438A1 (de) 2011-08-19 2013-02-20 Bionorica Se Verfahren zur Herstellung von Trockenextrakten
CN104066424A (zh) 2011-09-02 2014-09-24 伯特氏农场有限责任公司 包含小果南瓜或大果南瓜提取物的个人护理组合物
EP2606902A1 (de) 2011-12-19 2013-06-26 Bionorica SE Extrakt aus Rhus copallina als Arzneimittel
EP2620155A1 (de) 2012-01-30 2013-07-31 Bionorica SE Arzneimittel enthaltend Cimicifuga zur Anwendung bei der Behandlung von Sarkopenie und Herzmuskelschwäche
EP2810650A1 (de) * 2013-06-06 2014-12-10 Bionorica Se Arzneimittel enthaltend Thymian und Primel oder Thymian und Efeu als PDE-4-Hemmer
JP2014237608A (ja) * 2013-06-07 2014-12-18 株式会社日本食品薬化 エストロゲン様作用剤、メラニン産生抑制作用剤、皮膚外用剤および美容用飲食品
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
TR201814180T4 (tr) 2014-10-17 2018-11-21 Bionorica Se Prostati̇t tedavi̇si̇ i̇çi̇n kanefron
CN104800324A (zh) * 2015-05-11 2015-07-29 李汶峰 一种治疗前列腺肥大的中药
WO2022133555A1 (pt) * 2020-12-23 2022-06-30 Lithocálcio Indústria, Comércio, Importação, Exportação E Representação Ltda. Composição farmacêutica sólida contendo vitamina d e sal de cálcio, método para tratar ou prevenir condições relacionadas a baixa ingestão e/ou maior necessidade de cálcio, uso da composição farmacêutica sólida e produto farmacêutico ou suplementar

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410417A (en) * 1944-03-04 1946-11-05 Lever Brothers Ltd Vitamin and mineral dietary supplement and method of making
NL255509A (hu) * 1959-09-02
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US4681766A (en) 1986-01-07 1987-07-21 Warner-Lambert Company Coatings for chewing gums containing gum arabic and a soluble calcium salt
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5093130A (en) * 1989-09-26 1992-03-03 Plant Genetics Powder coated hydrogel capsules
EP0610060A1 (en) 1993-02-01 1994-08-10 Conrad Gorinsky Bisbenzylisoquinoline derivatives
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) * 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
BR9806238A (pt) 1997-09-09 2005-07-12 Select Release L C Partìculas revestidas: processos de obtenção e uso
CN1179972A (zh) 1997-09-29 1998-04-29 杨成玉 多能口洁泡腾片
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
US20050037100A1 (en) 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
DE19812204A1 (de) 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
DE19814905A1 (de) * 1998-04-02 1999-10-07 Michael O Ruepp Aar Pharma Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten
US6444018B1 (en) * 1998-06-25 2002-09-03 Xerox Corporation Phase change ink carrier compositions containing anhydride/amino alcohol-based adducts
GB9813906D0 (en) * 1998-06-26 1998-08-26 Isis Innovations Ltd Coatings
KR100267576B1 (ko) * 1998-07-25 2000-11-01 허계성 활성성분을 분리함유한 츄잉 연질정제 및 그의 제조방법
AU4549699A (en) * 1998-07-30 2000-02-21 Warner-Lambert Company Centerfill delivery system for nutraceuticals
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
AR020343A1 (es) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion.
US6200594B1 (en) * 1999-12-29 2001-03-13 Vital Dynamics, Inc. Breast-enhancing, herbal compositions and methods of using same
DE10127897B4 (de) 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten

Also Published As

Publication number Publication date
SK16402003A3 (sk) 2004-05-04
CN100376267C (zh) 2008-03-26
PL370446A1 (en) 2005-05-30
ATE311195T1 (de) 2005-12-15
US7629005B2 (en) 2009-12-08
JP2004534058A (ja) 2004-11-11
US20040151781A1 (en) 2004-08-05
LT2004002A (en) 2004-03-25
RO122659B1 (ro) 2009-11-30
DE50205118D1 (de) 2006-01-05
EP1392337B2 (de) 2009-07-22
ES2250674T3 (es) 2006-04-16
HUP0400125A3 (en) 2005-11-28
BG108419A (en) 2004-11-30
CZ305121B6 (cs) 2015-05-13
EP1392337A1 (de) 2004-03-03
SK287722B6 (en) 2011-07-06
CA2449521C (en) 2010-09-21
DE10127897A1 (de) 2002-12-19
KR100894848B1 (ko) 2009-04-24
BG66394B1 (bg) 2013-12-31
JP4945058B2 (ja) 2012-06-06
EE200400006A (et) 2004-02-16
GEP20053591B (en) 2005-07-25
HUP0400125A2 (hu) 2004-08-30
DK1392337T3 (da) 2005-12-27
CZ20033578A3 (en) 2004-04-14
UA76464C2 (uk) 2006-08-15
EP1392337B1 (de) 2005-11-30
KR20040011517A (ko) 2004-02-05
US20100068273A1 (en) 2010-03-18
AU2002317720B2 (en) 2007-06-21
LT5146B (lt) 2004-07-26
NO20035274D0 (no) 2003-11-27
EE05360B1 (et) 2010-12-15
WO2002100422A1 (de) 2002-12-19
DE10127897B4 (de) 2006-04-20
NZ529779A (en) 2006-04-28
CN1514732A (zh) 2004-07-21
BR0210262A (pt) 2004-06-22
MXPA03011102A (es) 2004-12-06
EA200400001A1 (ru) 2004-06-24
CA2449521A1 (en) 2002-12-19
ES2250674T5 (es) 2009-11-06
DK1392337T4 (da) 2009-09-21
EA006760B1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
LV13127B (en) Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
DE4329794C2 (de) Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE69826113T2 (de) R- und s- enantiomere getrennteteile enthaltende dosierungsformen
DE69000881T2 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
DE69431247T2 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DE69826290T2 (de) Pharmazeutische zusammensetzungen zur kontrollierten freigabe von wirkstoffen
DE69720055T2 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
DE3046559A1 (de) Im colon zerfallende tabletten und ihre herstellung
EP3446696A1 (de) Verwendung eines extraktes aus blättern von ginkgo biloba
DE10213571A1 (de) Pflanzenextrakte und deren Anwendung
EP2320922B1 (de) Kombination von extrakten aus verschiedenen pflanzen zur verbesserung der symptome von demenzerkrankungen
EP0914823B1 (de) Orale Retard-Präparation enthaltend Tramadol sowie Verfahren zu ihrer Herstellung
WO2009036906A1 (de) Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation
DE202006011920U1 (de) Zusammensetzung zur Behandlung von Rhinitis
EP1928441A2 (de) Retardformulierung von 3-(2-dimethylaminomethyl-cyclohexyl)-phenol
EP1682162A1 (de) Verwendung von feigenkaktus (opuntia) pflanzenteilen und/oder extrakten zur behandlung von depressionen
DE60201117T2 (de) Mikrogranulate von Ursodeoxycholsäure
WO1997044051A1 (de) Gereinigter extrakt von harpagophytum procumbens und/oder harpagophytum zeyheri dence, verfahren zu seiner herstellung und seine verwendung
WO2020148125A1 (de) Verfahren zur herstellung von leicht einzunehmenden tabletten mit trockenextrakt aus ginkgo biloba blättern
WO2004078189A1 (de) Verwendung von rutin und isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen sowei bei anderen affektiven störungen
DE102018105197A1 (de) Ein arzneimittel zur behandlung von zahnschmerzen und ein verfahren zu dessen herstellung
DE4237551C1 (de) Verwendung einer Zusammensetzung auf pflanzlicher Basis zur Bekämpfung von Dermatomykosen
DE2551962C3 (de) Verwendung eines Extraktes aus verschiedenen Spezies von Helleborus
DE10131057A1 (de) Weiche, Angelikaöl enthaltende Gelkapsel und deren Herstellung
DE10152469A1 (de) 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung